董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bradley Karro | 男 | Director | 55 | 20.50万美元 | 未持股 | 2017-04-13 |
| Paul Keckley | 男 | Director | 67 | 19.50万美元 | 未持股 | 2017-04-13 |
| Conan J. Laughlin | 男 | Director | 44 | 21.00万美元 | 未持股 | 2017-04-13 |
| Robert Greczyn | 男 | Director | 65 | 19.50万美元 | 未持股 | 2017-04-13 |
| Lee Shapiro | 男 | Director | 61 | 21.50万美元 | 未持股 | 2017-04-13 |
| Archelle Georgiou | 女 | Director | 54 | 15.54万美元 | 未持股 | 2017-04-13 |
| Peter Hudson | 男 | Director | 51 | 15.83万美元 | 未持股 | 2017-04-13 |
| Kevin G. Wills | 男 | Chairman of the Board | 51 | 30.00万美元 | 未持股 | 2017-04-13 |
| Donato Tramuto | 男 | Chief Executive Officer and Director | 60 | 255.64万美元 | 未持股 | 2017-04-13 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Glenn Hargreaves | -- | Chief Accounting Officer and Interim Chief Financial Officer | 57 | 103.21万美元 | 未持股 | 2017-04-13 |
| Mary Flipse | -- | Chief Legal Officer | 57 | 64.64万美元 | 未持股 | 2017-04-13 |
| Donato Tramuto | 男 | Chief Executive Officer and Director | 60 | 255.64万美元 | 未持股 | 2017-04-13 |
董事简历
中英对照 | 中文 | 英文- Bradley Karro
-
Bradley Karro，现任Hillcote Advisors的负责人，该公司由他在2008年7月创立，专注于医疗保健公司的投资和重组业务。此前，他在医疗保健行业担任过一些高级执行职位，其中包括处方福利管理公司Caremark Rx的执行副总裁。他于1998年加入Medpartners，后来更名为Caremark Rx ，在该工作直到2007年。在此期间，他负责Caremark Rx的并购、整合规划、信息技术、医疗护理产品开发。他曾被任命为田纳西州Governor's e-Health Advisory Council的成员，该机构致力于协调全州的努力，争取电子病历的采用。他现为Angiotech Pharmaceuticals, Inc的董事、审计委员会主席；曾担任Emageon Inc.的董事。
Bradley Karro is a principal of Hillcote Advisors, a firm focused on investing in and restructuring healthcare companies that Mr. Karro founded in July 2008. Prior to starting Hillcote Advisors, Mr. Karro held a number of senior executive positions in the healthcare industry, including serving as Executive Vice President of Caremark Rx, a prescription benefit management company. Mr. Karro joined Medpartners which changed its name to Caremark Rx in 1998 and served at Caremark Rx through 2007. During his time at Caremark Rx, Mr. Karro was responsible for mergers and acquisitions, integration planning, information technology and Medicare product development. Mr. Karro was also appointed as a charter member of the Governor's e-Health Advisory Council in Tennessee, an organization established to coordinate Tennessee's initiatives leading towards the adoption of electronic medical records. From October 2013 to March 2017 Mr. Karro served as a member of the Board of Directors of Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, where he chaired the Audit Committee. Mr. Karro previously served on the Board of Directors of Emageon Inc., an information technology systems provider for hospitals, healthcare networks, and imaging facilities, from 2008 through 2009. - Bradley Karro，现任Hillcote Advisors的负责人，该公司由他在2008年7月创立，专注于医疗保健公司的投资和重组业务。此前，他在医疗保健行业担任过一些高级执行职位，其中包括处方福利管理公司Caremark Rx的执行副总裁。他于1998年加入Medpartners，后来更名为Caremark Rx ，在该工作直到2007年。在此期间，他负责Caremark Rx的并购、整合规划、信息技术、医疗护理产品开发。他曾被任命为田纳西州Governor's e-Health Advisory Council的成员，该机构致力于协调全州的努力，争取电子病历的采用。他现为Angiotech Pharmaceuticals, Inc的董事、审计委员会主席；曾担任Emageon Inc.的董事。
- Bradley Karro is a principal of Hillcote Advisors, a firm focused on investing in and restructuring healthcare companies that Mr. Karro founded in July 2008. Prior to starting Hillcote Advisors, Mr. Karro held a number of senior executive positions in the healthcare industry, including serving as Executive Vice President of Caremark Rx, a prescription benefit management company. Mr. Karro joined Medpartners which changed its name to Caremark Rx in 1998 and served at Caremark Rx through 2007. During his time at Caremark Rx, Mr. Karro was responsible for mergers and acquisitions, integration planning, information technology and Medicare product development. Mr. Karro was also appointed as a charter member of the Governor's e-Health Advisory Council in Tennessee, an organization established to coordinate Tennessee's initiatives leading towards the adoption of electronic medical records. From October 2013 to March 2017 Mr. Karro served as a member of the Board of Directors of Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, where he chaired the Audit Committee. Mr. Karro previously served on the Board of Directors of Emageon Inc., an information technology systems provider for hospitals, healthcare networks, and imaging facilities, from 2008 through 2009.
- Paul Keckley
-
Paul Keckley，2014年3月至今，担任 Navigant Center for Healthcare Research and Policy Analysis的总经理。另外，他还是《The Keckley Report》的编辑，他于2013年9月开始发行；他是卫生行业趋势、美国卫生系统改革的专家。他在卫生行业工作了35年，他曾是医疗改革全国性媒体报道的专家评论员，在私人投资者注资的4家健康护理公司担任过首席执行官，在担任过多个高管职务，最后的是华盛顿特区Deloitte Center for Health Solutions的执行总监，任期2006年至2013年9月。他目前是Western Governors University, Oration Inc. ,Lipscomb University College of Pharmacy的顾问委员会成员，也是Health Executive Network的成员。
Paul Keckley was the Managing Director of Navigant Center for Healthcare Research and Policy Analysis from March 2014 through February 2016. In addition, Dr. Keckley is the Editor of The Keckley Report, which he began publishing in September 2013 and an expert on health industry trends and U.S. health system reform. In his 35-year health industry career, Dr. Keckley served as an expert commentator for national media coverage of healthcare reform, CEO of four health care companies funded by private investors, in senior management at Vanderbilt Medical Center and most recently as Executive Director of the Deloitte Center for Health Solutions in Washington, D.C, a position he held from 2006 through September 2013. Dr. Keckley currently serves on the Advisory Boards of Western Governors University, Oration Inc., and Lipscomb University College of Pharmacy and is a member of the Health Executive Network. - Paul Keckley，2014年3月至今，担任 Navigant Center for Healthcare Research and Policy Analysis的总经理。另外，他还是《The Keckley Report》的编辑，他于2013年9月开始发行；他是卫生行业趋势、美国卫生系统改革的专家。他在卫生行业工作了35年，他曾是医疗改革全国性媒体报道的专家评论员，在私人投资者注资的4家健康护理公司担任过首席执行官，在担任过多个高管职务，最后的是华盛顿特区Deloitte Center for Health Solutions的执行总监，任期2006年至2013年9月。他目前是Western Governors University, Oration Inc. ,Lipscomb University College of Pharmacy的顾问委员会成员，也是Health Executive Network的成员。
- Paul Keckley was the Managing Director of Navigant Center for Healthcare Research and Policy Analysis from March 2014 through February 2016. In addition, Dr. Keckley is the Editor of The Keckley Report, which he began publishing in September 2013 and an expert on health industry trends and U.S. health system reform. In his 35-year health industry career, Dr. Keckley served as an expert commentator for national media coverage of healthcare reform, CEO of four health care companies funded by private investors, in senior management at Vanderbilt Medical Center and most recently as Executive Director of the Deloitte Center for Health Solutions in Washington, D.C, a position he held from 2006 through September 2013. Dr. Keckley currently serves on the Advisory Boards of Western Governors University, Oration Inc., and Lipscomb University College of Pharmacy and is a member of the Health Executive Network.
- Conan J. Laughlin
-
Conan J. Laughlin，他是North Tide Capital公司（总部位于波士顿的投资公司，他于2011年9月创立的公司）的创始人、投资经理和管理成员。公司投资于全球股市，利用价值导向专注于医疗保健行业。他曾从事医疗行业，担任股票研究分析师（1995年以来）。创立North Tide Capital公司之前（从2005年到2011年），他曾担任Millennium Management公司（一个数十亿美元的投资公司，总部设在纽约）的投资组合经理兼副顾问。从2002年到2004年，他曾担任高级分析师，任职于American Express公司（位于波士顿）的资产管理集团的医疗保健部门。2002年加入American Express公司之前，他曾担任Morgan Stanley Dean Witter公司（从1995年到1997年）、 SG Cowen公司（从1997年到1999年）、Deutsche Bank Alex.Brown（从1999年到2002年）的卖方分析师。他目前任职于The Park School（位于布鲁克莱恩）的监事会。
Conan J. Laughlin is the Founder, Portfolio Manager, and Managing Member of North Tide Capital, a Boston-based investment firm that Mr. Laughlin launched in September 2011. The firm invests in global equities utilizing a value-oriented approach with a dedicated focus on the healthcare sector. Mr. Laughlin has covered the healthcare industry as an equity research analyst since 1995. Prior to founding North Tide Capital, from 2005-2011 Mr. Laughlin was a portfolio manager and sub-adviser to Millennium Management LLC, a multi-billion dollar investment firm based in New York. From 2002-2004 Mr. Laughlin was a senior analyst covering the healthcare sector in the Asset Management group at American Express in Boston. Prior to joining American Express in 2002 he spent seven years as a sell-side analyst at Morgan Stanley Dean Witter 1995-1997 SG Cowen (1997-1999), and Deutsche Bank Alex. Brown (1999-2002). Mr. Laughlin currently serves on the Board of Trustees at The Park School in Brookline, Massachusetts as a member of the finance, audit, and buildings and grounds committees. - Conan J. Laughlin，他是North Tide Capital公司（总部位于波士顿的投资公司，他于2011年9月创立的公司）的创始人、投资经理和管理成员。公司投资于全球股市，利用价值导向专注于医疗保健行业。他曾从事医疗行业，担任股票研究分析师（1995年以来）。创立North Tide Capital公司之前（从2005年到2011年），他曾担任Millennium Management公司（一个数十亿美元的投资公司，总部设在纽约）的投资组合经理兼副顾问。从2002年到2004年，他曾担任高级分析师，任职于American Express公司（位于波士顿）的资产管理集团的医疗保健部门。2002年加入American Express公司之前，他曾担任Morgan Stanley Dean Witter公司（从1995年到1997年）、 SG Cowen公司（从1997年到1999年）、Deutsche Bank Alex.Brown（从1999年到2002年）的卖方分析师。他目前任职于The Park School（位于布鲁克莱恩）的监事会。
- Conan J. Laughlin is the Founder, Portfolio Manager, and Managing Member of North Tide Capital, a Boston-based investment firm that Mr. Laughlin launched in September 2011. The firm invests in global equities utilizing a value-oriented approach with a dedicated focus on the healthcare sector. Mr. Laughlin has covered the healthcare industry as an equity research analyst since 1995. Prior to founding North Tide Capital, from 2005-2011 Mr. Laughlin was a portfolio manager and sub-adviser to Millennium Management LLC, a multi-billion dollar investment firm based in New York. From 2002-2004 Mr. Laughlin was a senior analyst covering the healthcare sector in the Asset Management group at American Express in Boston. Prior to joining American Express in 2002 he spent seven years as a sell-side analyst at Morgan Stanley Dean Witter 1995-1997 SG Cowen (1997-1999), and Deutsche Bank Alex. Brown (1999-2002). Mr. Laughlin currently serves on the Board of Trustees at The Park School in Brookline, Massachusetts as a member of the finance, audit, and buildings and grounds committees.
- Robert Greczyn
-
Robert Greczyn，也曾担任Blue Cross Blue Shield of North Carolina "BCBSNC"的首席执行官（从2000年到2010年退休），在那里他也曾任职于the Blue Cross Blue Shield Association的董事会。退休以来，他曾担任Capital Food Group, LLC、RJG Restaurant Group LLC（私营餐饮特许经营）的负责人。从1998年8月到1999年9月，他曾担任BCBSNC的首席运营官，并于1999年9月成为总裁。此前，他曾担任Carolina Physicians Health Plan（健康维护组织，于1991年被Healthsource, Inc收购，最终于1994年被Healthsource, Inc.收购，成为Healthsource North Carolina）的总裁兼首席执行官（1990年至1998年）。Cigna Corporation于1997年收购Healthsource, Inc.此前，他曾担任Health Plan of Delaware, Ltd.（于1988年被Principal Health Care, Inc.收购，成为Principal Health Care of Delaware, Inc.）的总裁兼首席执行官（1986年至1990年）。2011年3月至2014年11月，他曾任职于Liposcience, Inc.（上市临床诊断公司，于2014年11月被Laboratory Corporation of America收购）的董事会，在那里他曾主管薪酬委员会，也曾担任审计委员会的成员。他也曾担任Liposcience, Inc的临时总裁兼首席执行官（2013年8月至2014年2月），期间退任审计和薪酬委员会。此外，他曾担任M*Modal Inc.（交互式临床文档和语音理解技术的供应商，上市公司，于2012年8月被One Equity Partners收购）的董事（2011年10月至2012年8月），在那里他曾担任薪酬委员会和审计委员会的成员。2006年至2008年，他曾担任the Council for Affordable Quality Care（全国领先的医疗保险公司的首席执行官联盟，致力于简化医疗事务）的董事会主席。他持有北卡罗来纳大学教堂山分校（the University of North Carolina at Chapel Hill）的卫生政策硕士学位，以及East Carolina University的心理学学士学位。
Robert Greczyn was the Chief Executive Officer of Blue Cross Blue Shield of North Carolina "BCBSNC" from 2000 until his retirement in 2010 where he also served on the Board of the Blue Cross Blue Shield Association. Since his retirement, Mr. Greczyn has served as Principal Manager of Capital Food Group, LLC and RJG Restaurant Group LLC, privately held restaurant franchise operations. From August 1998 until September 1999 he was the Chief Operating Officer of BCBSNC and became its President in September 1999. Prior to that, from 1990 to 1998 he was the President and CEO of Carolina Physicians Health Plan, a health maintenance organization, which was partially acquired by Healthsource, Inc. in 1991 and fully acquired by Healthsource, Inc. in 1994 at which time it became Healthsource North Carolina. In 1997 Cigna Corporation acquired Healthsource, Inc. Prior to that, Mr. Greczyn was President and CEO of Health Plan of Delaware, Ltd. (which was acquired by Principal Health Care, Inc. in 1988 at which time it became Principal Health Care of Delaware, Inc.) from 1986 to 1990. From March 2011 to November 2014 Mr. Greczyn served on the Board of Directors of Liposcience, Inc., a publicly traded (until its acquisition by Laboratory Corporation of America in November 2014) clinical diagnostic company, where he chaired the compensation committee and was a member of the audit committee. He also served as the interim President and Chief Executive Officer of Liposcience, Inc. from August 2013 until February 2014 during which time he resigned from his positions on the audit and compensation committees. In addition, from October 2011 until August 2012 Mr. Greczyn served as a director of M*Modal Inc., a publicly traded (until its acquisition August 2012 by One Equity Partners) provider of interactive clinical documentation and speech understanding technology, where he was a member of the compensation and audit committees. From 2006 to 2008 Mr. Greczyn was Chairman of the Board of the Council for Affordable Quality Care, an alliance of chief executive officers of the nation's leading health insurers working to simplify healthcare transactions. Mr. Greczyn received an M.P.H. degree in health policy from the University of North Carolina at Chapel Hill and a B.A. degree in psychology from East Carolina University. - Robert Greczyn，也曾担任Blue Cross Blue Shield of North Carolina "BCBSNC"的首席执行官（从2000年到2010年退休），在那里他也曾任职于the Blue Cross Blue Shield Association的董事会。退休以来，他曾担任Capital Food Group, LLC、RJG Restaurant Group LLC（私营餐饮特许经营）的负责人。从1998年8月到1999年9月，他曾担任BCBSNC的首席运营官，并于1999年9月成为总裁。此前，他曾担任Carolina Physicians Health Plan（健康维护组织，于1991年被Healthsource, Inc收购，最终于1994年被Healthsource, Inc.收购，成为Healthsource North Carolina）的总裁兼首席执行官（1990年至1998年）。Cigna Corporation于1997年收购Healthsource, Inc.此前，他曾担任Health Plan of Delaware, Ltd.（于1988年被Principal Health Care, Inc.收购，成为Principal Health Care of Delaware, Inc.）的总裁兼首席执行官（1986年至1990年）。2011年3月至2014年11月，他曾任职于Liposcience, Inc.（上市临床诊断公司，于2014年11月被Laboratory Corporation of America收购）的董事会，在那里他曾主管薪酬委员会，也曾担任审计委员会的成员。他也曾担任Liposcience, Inc的临时总裁兼首席执行官（2013年8月至2014年2月），期间退任审计和薪酬委员会。此外，他曾担任M*Modal Inc.（交互式临床文档和语音理解技术的供应商，上市公司，于2012年8月被One Equity Partners收购）的董事（2011年10月至2012年8月），在那里他曾担任薪酬委员会和审计委员会的成员。2006年至2008年，他曾担任the Council for Affordable Quality Care（全国领先的医疗保险公司的首席执行官联盟，致力于简化医疗事务）的董事会主席。他持有北卡罗来纳大学教堂山分校（the University of North Carolina at Chapel Hill）的卫生政策硕士学位，以及East Carolina University的心理学学士学位。
- Robert Greczyn was the Chief Executive Officer of Blue Cross Blue Shield of North Carolina "BCBSNC" from 2000 until his retirement in 2010 where he also served on the Board of the Blue Cross Blue Shield Association. Since his retirement, Mr. Greczyn has served as Principal Manager of Capital Food Group, LLC and RJG Restaurant Group LLC, privately held restaurant franchise operations. From August 1998 until September 1999 he was the Chief Operating Officer of BCBSNC and became its President in September 1999. Prior to that, from 1990 to 1998 he was the President and CEO of Carolina Physicians Health Plan, a health maintenance organization, which was partially acquired by Healthsource, Inc. in 1991 and fully acquired by Healthsource, Inc. in 1994 at which time it became Healthsource North Carolina. In 1997 Cigna Corporation acquired Healthsource, Inc. Prior to that, Mr. Greczyn was President and CEO of Health Plan of Delaware, Ltd. (which was acquired by Principal Health Care, Inc. in 1988 at which time it became Principal Health Care of Delaware, Inc.) from 1986 to 1990. From March 2011 to November 2014 Mr. Greczyn served on the Board of Directors of Liposcience, Inc., a publicly traded (until its acquisition by Laboratory Corporation of America in November 2014) clinical diagnostic company, where he chaired the compensation committee and was a member of the audit committee. He also served as the interim President and Chief Executive Officer of Liposcience, Inc. from August 2013 until February 2014 during which time he resigned from his positions on the audit and compensation committees. In addition, from October 2011 until August 2012 Mr. Greczyn served as a director of M*Modal Inc., a publicly traded (until its acquisition August 2012 by One Equity Partners) provider of interactive clinical documentation and speech understanding technology, where he was a member of the compensation and audit committees. From 2006 to 2008 Mr. Greczyn was Chairman of the Board of the Council for Affordable Quality Care, an alliance of chief executive officers of the nation's leading health insurers working to simplify healthcare transactions. Mr. Greczyn received an M.P.H. degree in health policy from the University of North Carolina at Chapel Hill and a B.A. degree in psychology from East Carolina University.
- Lee Shapiro
-
Lee Shapiro， 他一直担任7wire Ventures公司（他共同创立的一家风险投资公司，从事创新想法和企业家的投资，主要是消费主导型医疗保健和教育技术等领域）的管理合伙人（2013年以来）。此前，他曾担任Allscripts Healthcare Solutions, Inc.（一个上市医疗卫生信息技术公司，Allscripts）总裁（2002年至2012年12月），也曾担任Allscripts公司的首席执行官顾问（2013年1月至2013年6月）。加入Allscripts公司之前，他曾担任Douglas Elliman-Beitler公司（商业办公管理和开发公司）的首席运营官（从1998年到2000年），在那里他曾领导所有美国商业活动，职业生涯中，他也担任SES Properties, Inc.的总裁、City Financial Bancorp的副董事长，并在Barack、Ferrazzano、Kirschbaum、Perlman & Nagelberg从事商法实践。除了任职一些私营公司的董事会，他目前任职于Medidata Solutions, Inc. （一个公开交易的全球生命科学云解决方案的供应商，在那里他担任审计委员会和提名和公司治理委员会的成员）、 Aptus Health, Inc（Merck & Co., Inc.的全资子公司，专业医学团队 的医疗信息、药物样品和移动决策支持工具的网络资源的最大供应商之一，原为Physicians Interactive Holdings, LLC，"PIH"，在那里他主管审计委员会，并担任薪酬委员会的成员）、the American Heart Association的董事会。2009年至2010年，他也曾被任命到伊利诺伊州的经济复苏委员会（the Economic Recovery Commission of the State of Illinois）。他获得The University of Chicago Law School的法学博士学位。
Lee Shapiro, one of our directors, is the Chief Financial Officer of Livongo and Managing Partner at 7Wire, an investment firm he co-founded over a decade ago. Previously, he was President of Allscripts from 2002 to 2012. Mr. Shapiro's responsibilities included the company's strategy, international operations, business development and partnerships, legal, government relations, health plan initiatives and business activities in the areas of analytics and information services. At times during his tenure at Allscripts, he served as the company's Chief Operating Officer leveraging his unique grasp of the business operations across the spectrum of development, sales, marketing, services and support. Mr. Shapiro previously served on the board of directors of Livongo, where he chaired the audit committee and served as a member of the compensation committee. He also was a member of the executive leadership team, with a focus on strategy and business development. Mr. Shapiro served on the board of directors of Medidata Nasdaq: MDSO, where he served on the audit committee and nominating and governance committee, from 2011 until its sale to Dassault in 2019. Mr. Shapiro also served on the board of Tivity (Nasdaq: TVTY), where he chaired the audit committee and served on the compensation committee, from 2015 until May 2020. He also currently serves on the board and committees of various 7Wire portfolio companies. Since 2016 Mr. Shapiro has been a member of the National Board of Directors of the American Heart Association, where he chairs the audit committee and serves on the business operations committee. Mr. Shapiro practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. Mr. Shapiro holds a JD degree from The University of Chicago Law School and a BS in Accounting from the University of Illinois. - Lee Shapiro， 他一直担任7wire Ventures公司（他共同创立的一家风险投资公司，从事创新想法和企业家的投资，主要是消费主导型医疗保健和教育技术等领域）的管理合伙人（2013年以来）。此前，他曾担任Allscripts Healthcare Solutions, Inc.（一个上市医疗卫生信息技术公司，Allscripts）总裁（2002年至2012年12月），也曾担任Allscripts公司的首席执行官顾问（2013年1月至2013年6月）。加入Allscripts公司之前，他曾担任Douglas Elliman-Beitler公司（商业办公管理和开发公司）的首席运营官（从1998年到2000年），在那里他曾领导所有美国商业活动，职业生涯中，他也担任SES Properties, Inc.的总裁、City Financial Bancorp的副董事长，并在Barack、Ferrazzano、Kirschbaum、Perlman & Nagelberg从事商法实践。除了任职一些私营公司的董事会，他目前任职于Medidata Solutions, Inc. （一个公开交易的全球生命科学云解决方案的供应商，在那里他担任审计委员会和提名和公司治理委员会的成员）、 Aptus Health, Inc（Merck & Co., Inc.的全资子公司，专业医学团队 的医疗信息、药物样品和移动决策支持工具的网络资源的最大供应商之一，原为Physicians Interactive Holdings, LLC，"PIH"，在那里他主管审计委员会，并担任薪酬委员会的成员）、the American Heart Association的董事会。2009年至2010年，他也曾被任命到伊利诺伊州的经济复苏委员会（the Economic Recovery Commission of the State of Illinois）。他获得The University of Chicago Law School的法学博士学位。
- Lee Shapiro, one of our directors, is the Chief Financial Officer of Livongo and Managing Partner at 7Wire, an investment firm he co-founded over a decade ago. Previously, he was President of Allscripts from 2002 to 2012. Mr. Shapiro's responsibilities included the company's strategy, international operations, business development and partnerships, legal, government relations, health plan initiatives and business activities in the areas of analytics and information services. At times during his tenure at Allscripts, he served as the company's Chief Operating Officer leveraging his unique grasp of the business operations across the spectrum of development, sales, marketing, services and support. Mr. Shapiro previously served on the board of directors of Livongo, where he chaired the audit committee and served as a member of the compensation committee. He also was a member of the executive leadership team, with a focus on strategy and business development. Mr. Shapiro served on the board of directors of Medidata Nasdaq: MDSO, where he served on the audit committee and nominating and governance committee, from 2011 until its sale to Dassault in 2019. Mr. Shapiro also served on the board of Tivity (Nasdaq: TVTY), where he chaired the audit committee and served on the compensation committee, from 2015 until May 2020. He also currently serves on the board and committees of various 7Wire portfolio companies. Since 2016 Mr. Shapiro has been a member of the National Board of Directors of the American Heart Association, where he chairs the audit committee and serves on the business operations committee. Mr. Shapiro practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. Mr. Shapiro holds a JD degree from The University of Chicago Law School and a BS in Accounting from the University of Illinois.
- Archelle Georgiou
-
Archelle Georgiou是Georgiou Consulting，LLC的总裁，该公司是她于2007年12月创立的一家梦百合咨询公司。1995年至2007年，Georgiou博士曾在UnitedHealth Group Corporation担任多个执行级别的职位，包括国家医疗总监、首席医疗官、首席执行官-护理管理，最后担任执行Vice President-战略关系、专业护理服务。在她的职业生涯中，Georgiou博士就梦百合行业的最新新闻和趋势作出了许多媒体贡献，包括自2007年1月以来担任明尼苏达州明尼阿波利斯-圣保罗每周两次的电视节目的梦百合专家和媒体记者。Georgiou博士自2014年3月起担任明尼苏达大学卡尔森商学院（University of Minnesota Carlson School of Business）的讲师。2011年至2014年，Georgiou博士担任TripleTree（一家专门从事梦百合的商业银行和战略咨询公司）的高级顾问，以及Health Executive Roundtable（一家专注于梦百合行业创新变革的梦百合智囊团）的主席。从2010年到2015年，Georgiou博士担任PRGXGlobal，Inc.的董事会成员，该公司是一家恢复审计服务的公开交易提供商，她在该公司担任提名和治理委员会主席。Georgiou博士于1986年毕业于约翰霍普金斯医学院（Johns Hopkins School of Medicine）。在过渡到梦百合管理和政策之前，她在加利福尼亚北部接受了内科培训和实践。
Archelle Georgiou is the president of Georgiou Consulting, LLC, a healthcare consulting firm that she founded in December of 2007. From 1995 to 2007 Dr. Georgiou worked for UnitedHealth Group Corporation in numerous executive-level positions, including National Medical Director, Chief Medical Officer, CEO - Care Management, and culminating with her position as Executive Vice President - Strategic Relations, Specialized Care Services. Over the course of her career, Dr. Georgiou has made numerous media contributions regarding the latest healthcare industry news and trends, including, since January 2007 as a healthcare expert and media correspondent for a twice weekly television segment in Minneapolis-St. Paul, Minnesota. Since March 2014 Dr. Georgiou has been an instructor at the University of Minnesota Carlson School of Business. From 2011 to 2014 Dr. Georgiou served as Senior Advisor to TripleTree, a merchant bank and strategic advisory firm solely focused on healthcare, and Chair of Health Executive Roundtable, a healthcare think tank focusing on innovative changes in the healthcare industry. From 2010 to 2015 Dr. Georgiou served on the Board of Directors of PRGX Global, Inc., a publicly traded provider of recovery audit services, where she was the chair of the nominating and governance committee. Dr. Georgiou graduated from the Johns Hopkins School of Medicine in 1986. She trained and practiced in internal medicine in Northern California before transitioning into healthcare administration and policy. - Archelle Georgiou是Georgiou Consulting，LLC的总裁，该公司是她于2007年12月创立的一家梦百合咨询公司。1995年至2007年，Georgiou博士曾在UnitedHealth Group Corporation担任多个执行级别的职位，包括国家医疗总监、首席医疗官、首席执行官-护理管理，最后担任执行Vice President-战略关系、专业护理服务。在她的职业生涯中，Georgiou博士就梦百合行业的最新新闻和趋势作出了许多媒体贡献，包括自2007年1月以来担任明尼苏达州明尼阿波利斯-圣保罗每周两次的电视节目的梦百合专家和媒体记者。Georgiou博士自2014年3月起担任明尼苏达大学卡尔森商学院（University of Minnesota Carlson School of Business）的讲师。2011年至2014年，Georgiou博士担任TripleTree（一家专门从事梦百合的商业银行和战略咨询公司）的高级顾问，以及Health Executive Roundtable（一家专注于梦百合行业创新变革的梦百合智囊团）的主席。从2010年到2015年，Georgiou博士担任PRGXGlobal，Inc.的董事会成员，该公司是一家恢复审计服务的公开交易提供商，她在该公司担任提名和治理委员会主席。Georgiou博士于1986年毕业于约翰霍普金斯医学院（Johns Hopkins School of Medicine）。在过渡到梦百合管理和政策之前，她在加利福尼亚北部接受了内科培训和实践。
- Archelle Georgiou is the president of Georgiou Consulting, LLC, a healthcare consulting firm that she founded in December of 2007. From 1995 to 2007 Dr. Georgiou worked for UnitedHealth Group Corporation in numerous executive-level positions, including National Medical Director, Chief Medical Officer, CEO - Care Management, and culminating with her position as Executive Vice President - Strategic Relations, Specialized Care Services. Over the course of her career, Dr. Georgiou has made numerous media contributions regarding the latest healthcare industry news and trends, including, since January 2007 as a healthcare expert and media correspondent for a twice weekly television segment in Minneapolis-St. Paul, Minnesota. Since March 2014 Dr. Georgiou has been an instructor at the University of Minnesota Carlson School of Business. From 2011 to 2014 Dr. Georgiou served as Senior Advisor to TripleTree, a merchant bank and strategic advisory firm solely focused on healthcare, and Chair of Health Executive Roundtable, a healthcare think tank focusing on innovative changes in the healthcare industry. From 2010 to 2015 Dr. Georgiou served on the Board of Directors of PRGX Global, Inc., a publicly traded provider of recovery audit services, where she was the chair of the nominating and governance committee. Dr. Georgiou graduated from the Johns Hopkins School of Medicine in 1986. She trained and practiced in internal medicine in Northern California before transitioning into healthcare administration and policy.
- Peter Hudson
-
Peter Hudson自2015年10月起担任梦百合风险投资公司Alta Partners的董事总经理。他也任职于众多董事会，包括U.S.Acute Care Solutions“USACS”（美国最大的急性护理公司之一）的董事会主席（2015年5月以来），以及紧急医疗医师（USACS的创始组织之一）的董事会主席（2014年7月以来）。此外，自2014年11月起，Hudson博士一直担任私募股权支持的Maestro Health的董事会成员，自2015年8月起，担任移动急性护理提供商DispatchHealth的董事会成员，并担任风险投资支持的AugMedix的高级顾问，该公司是一家私人控股公司，在信息技术服务和咨询行业运营，自2015年1月以来。2008年至2014年3月，Hudson博士担任iTriage LLC（一家移动梦百合公司，被Aetna收购）的首席执行官。Dr.Hudson从2013年10月到2014年3月担任Aetna消费者技术主管。Hudson从2001年到2010年担任Porter Hospitals（科罗拉多州丹佛市一家急诊医疗人员配置公司）急诊医生管理业务合伙人。Hudson博士是费城儿童医院（Children’s Hospital of Philadelphia）的科学与技术顾问委员会、黑石企业家网络指导委员会以及科罗拉多大学医学院（University of Colorado School of Medicine）校长创新基金的投资顾问委员会成员。Hudson博士是科罗拉多技术协会（Colorado Technology Association）2013年的年度企业家，也是第一夫人在2013年国情咨文中代表数字健康作为国家政策目标的嘉宾。他持有Colorado College的政治学学士学位和医学预科学位，以及the University of Colorado School of Medicine的医学博士学位。
Peter Hudson has served as a Managing Director at Alta Partners, a healthcare venture capital firm, since October 2015. He also serves on numerous boards, including Chairman of the Board of U.S. Acute Care Solutions "USACS", one of the nation's largest acute care companies, since May 2015 and Chairman of the Board of Emergency Medicine Physicians, one of USACS' founding organizations, since July 2014. In addition, Dr. Hudson has been on the board of directors for private-equity backed Maestro Health, since November 2014 mobile acute care provider, DispatchHealth, since August 2015 and has served as senior advisor to venture-backed Augmedix, a privately-held company that operates in the information technology services & consulting industry, since January 2015. From 2008 to March 2014 Dr. Hudson was Chief Executive Officer of iTriage LLC, a mobile healthcare company, which was acquired by Aetna. Dr. Hudson then served as Head of Consumer Technologies at Aetna from October 2013 through March 2014. From 2001 to 2010 Dr. Hudson was managing business partner for Emergency Physicians at Porter Hospitals, an emergency medicine staffing company in Denver, Colorado. Dr. Hudson is on the Science and Technology Advisory Board at Children's Hospital of Philadelphia, the Blackstone Entrepreneurs Network Steering Committee, and the investment advisory board for University of Colorado School of Medicine's Chancellor's Innovation Fund. Dr. Hudson was the Colorado Technology Association's Entrepreneur of the Year in 2013 and a guest of the First Lady at the State of the Union in 2013 representing digital health as a national policy objective. He holds a B.A. in Political Science and Pre-Med from Colorado College and an M.D. from the University of Colorado School of Medicine. - Peter Hudson自2015年10月起担任梦百合风险投资公司Alta Partners的董事总经理。他也任职于众多董事会，包括U.S.Acute Care Solutions“USACS”（美国最大的急性护理公司之一）的董事会主席（2015年5月以来），以及紧急医疗医师（USACS的创始组织之一）的董事会主席（2014年7月以来）。此外，自2014年11月起，Hudson博士一直担任私募股权支持的Maestro Health的董事会成员，自2015年8月起，担任移动急性护理提供商DispatchHealth的董事会成员，并担任风险投资支持的AugMedix的高级顾问，该公司是一家私人控股公司，在信息技术服务和咨询行业运营，自2015年1月以来。2008年至2014年3月，Hudson博士担任iTriage LLC（一家移动梦百合公司，被Aetna收购）的首席执行官。Dr.Hudson从2013年10月到2014年3月担任Aetna消费者技术主管。Hudson从2001年到2010年担任Porter Hospitals（科罗拉多州丹佛市一家急诊医疗人员配置公司）急诊医生管理业务合伙人。Hudson博士是费城儿童医院（Children’s Hospital of Philadelphia）的科学与技术顾问委员会、黑石企业家网络指导委员会以及科罗拉多大学医学院（University of Colorado School of Medicine）校长创新基金的投资顾问委员会成员。Hudson博士是科罗拉多技术协会（Colorado Technology Association）2013年的年度企业家，也是第一夫人在2013年国情咨文中代表数字健康作为国家政策目标的嘉宾。他持有Colorado College的政治学学士学位和医学预科学位，以及the University of Colorado School of Medicine的医学博士学位。
- Peter Hudson has served as a Managing Director at Alta Partners, a healthcare venture capital firm, since October 2015. He also serves on numerous boards, including Chairman of the Board of U.S. Acute Care Solutions "USACS", one of the nation's largest acute care companies, since May 2015 and Chairman of the Board of Emergency Medicine Physicians, one of USACS' founding organizations, since July 2014. In addition, Dr. Hudson has been on the board of directors for private-equity backed Maestro Health, since November 2014 mobile acute care provider, DispatchHealth, since August 2015 and has served as senior advisor to venture-backed Augmedix, a privately-held company that operates in the information technology services & consulting industry, since January 2015. From 2008 to March 2014 Dr. Hudson was Chief Executive Officer of iTriage LLC, a mobile healthcare company, which was acquired by Aetna. Dr. Hudson then served as Head of Consumer Technologies at Aetna from October 2013 through March 2014. From 2001 to 2010 Dr. Hudson was managing business partner for Emergency Physicians at Porter Hospitals, an emergency medicine staffing company in Denver, Colorado. Dr. Hudson is on the Science and Technology Advisory Board at Children's Hospital of Philadelphia, the Blackstone Entrepreneurs Network Steering Committee, and the investment advisory board for University of Colorado School of Medicine's Chancellor's Innovation Fund. Dr. Hudson was the Colorado Technology Association's Entrepreneur of the Year in 2013 and a guest of the First Lady at the State of the Union in 2013 representing digital health as a national policy objective. He holds a B.A. in Political Science and Pre-Med from Colorado College and an M.D. from the University of Colorado School of Medicine.
- Kevin G. Wills
-
Kevin G. Wills 是Saks有限公司行政副总裁及首席财务官。Wills先生自2007年5月任Saks公司行政总裁，首席财务官等职务。自2005年5月至2007年4月，Wills先生任Saks公司财务执行副总裁／首席会计师。自2003年2月至2005年4月任Parisian有限公司执行副总裁，该公司是家族企业，主要从事服装销售。在此之前，即于1999年9月曾被任命为Saks百货集团规划和管理部高级执行副总裁，于1998年9月任公司策略规划部高级副总裁，于1997年9月即他加入Saks公司起便担任公司财务副总裁。在加入公司之前，Wills先生曾在Tennessee Valley Authority任副总裁及财务总管，该公司是一家上市电力开发商。在此之前，Wills先生曾为Coopers业务经理及Lybrand公司业务经理，现被称为PriceWaterhouseCoopers公司，只要提供会计及金融等服务业务。
Kevin G. Wills,is currently Chief Financial Officer of Authentic Brands Group.Prior to joining Authentic Brands Group, he served as Chief Financial Officer of Pilot Company, a private company, from 2019 to 2023, and Chief Financial Officer of Tapestry Incorporated, a publicly traded company, from 2017 to 2019. Kevin G. Wills has been Chairman of the Board since November 2015.Mr. Wills served as Managing Director and Chief Financial Officer of AlixPartners, LLP, a global business advisory firm, from March 2014 to February 2017. Prior to that, he served as Executive Vice President and Chief Financial Officer of Saks Incorporated now a part of Hudson's Bay Company, a publicly traded (prior to the fourth quarter of 2013) retailer of fashion apparel, shoes, accessories, jewelry, cosmetics, and gifts, from May 2007 through November 2013. Mr. Wills served as Executive Vice President of Finance/Chief Accounting Officer of Saks Incorporated from May 2005 through April 2007 and as Executive Vice President of Operations for Parisian, Inc., a retailer, from February 2003 until April 2005. Prior to that, he was appointed Senior Vice President of Planning and Administration for Saks Department Store Group in September 1999 Senior Vice President of Strategic Planning in September 1998 and Vice President of Financial Reporting for Saks Incorporated in September 1997 when he joined Saks Incorporated. Prior to joining Saks Incorporated, Mr. Wills served as Vice President and Controller for Tennessee Valley Authority, an energy producer. Prior to that, Mr. Wills served as the Business Assurance Manager for Coopers and Lybrand (currently known as PricewaterhouseCoopers), an accounting and financial services firm. - Kevin G. Wills 是Saks有限公司行政副总裁及首席财务官。Wills先生自2007年5月任Saks公司行政总裁，首席财务官等职务。自2005年5月至2007年4月，Wills先生任Saks公司财务执行副总裁／首席会计师。自2003年2月至2005年4月任Parisian有限公司执行副总裁，该公司是家族企业，主要从事服装销售。在此之前，即于1999年9月曾被任命为Saks百货集团规划和管理部高级执行副总裁，于1998年9月任公司策略规划部高级副总裁，于1997年9月即他加入Saks公司起便担任公司财务副总裁。在加入公司之前，Wills先生曾在Tennessee Valley Authority任副总裁及财务总管，该公司是一家上市电力开发商。在此之前，Wills先生曾为Coopers业务经理及Lybrand公司业务经理，现被称为PriceWaterhouseCoopers公司，只要提供会计及金融等服务业务。
- Kevin G. Wills,is currently Chief Financial Officer of Authentic Brands Group.Prior to joining Authentic Brands Group, he served as Chief Financial Officer of Pilot Company, a private company, from 2019 to 2023, and Chief Financial Officer of Tapestry Incorporated, a publicly traded company, from 2017 to 2019. Kevin G. Wills has been Chairman of the Board since November 2015.Mr. Wills served as Managing Director and Chief Financial Officer of AlixPartners, LLP, a global business advisory firm, from March 2014 to February 2017. Prior to that, he served as Executive Vice President and Chief Financial Officer of Saks Incorporated now a part of Hudson's Bay Company, a publicly traded (prior to the fourth quarter of 2013) retailer of fashion apparel, shoes, accessories, jewelry, cosmetics, and gifts, from May 2007 through November 2013. Mr. Wills served as Executive Vice President of Finance/Chief Accounting Officer of Saks Incorporated from May 2005 through April 2007 and as Executive Vice President of Operations for Parisian, Inc., a retailer, from February 2003 until April 2005. Prior to that, he was appointed Senior Vice President of Planning and Administration for Saks Department Store Group in September 1999 Senior Vice President of Strategic Planning in September 1998 and Vice President of Financial Reporting for Saks Incorporated in September 1997 when he joined Saks Incorporated. Prior to joining Saks Incorporated, Mr. Wills served as Vice President and Controller for Tennessee Valley Authority, an energy producer. Prior to that, Mr. Wills served as the Business Assurance Manager for Coopers and Lybrand (currently known as PricewaterhouseCoopers), an accounting and financial services firm.
- Donato Tramuto
-
Donato Tramuto，2014年6月起担任董事会主席。Tramuto是 PIH的创始人之一，该公司在2013年出售给了Merck Global Health Innovation Fund GHIF。他从2008年至今担任PIH的首席执行官和主席。PIH是为专业医学团队 提供医疗信息网络资源、药物样品和移动决策支持工具的最大的供应商之一。2006年到2008年，他担任Allscripts医生互动部门董事长。2004年到2006年，Tramuto担任i3（一家全球制药服务公司）首席执行官；i3在2011年被inVentiv Health, Inc.收购之前，曾是Ingenix（UnitedHealth Group Incorporated的子公司）的一部分。1998年到2003年，Tramuto曾是Protocare, Inc.（一个大药物开发服务供应商）创始人之一，担任Protocare科学部门董事长和首席执行官以及Protocare企业长官。共同创立Protocare之前，Tramuto曾担任Caremark家庭医疗保健业务总经理/执行副总裁以及疾病管理营销副总裁。Tramuto还担任几家执行领导董事会成员，包括the Boston University School公共卫生院长顾问委员会、医生互动董事会、the Robert F. Kennedy Center for Justice、欧洲人权委员会和York Community Hospital受托人委员会。Tramuto是Health eVillages董事会主席和创始人，还是the State of Maine Economic Growth Council前成员，由前缅因州州长John Baldacci任命。
Donato Tramuto has served as Chief Executive Officer of the Company since November 2015. He was Chairman of the Board from June 2014 until becoming Chief ExecutiveOfficer in November 2015. From 2008 until November 2015 Mr. Tramuto served as Chief Executive Officer and Chairman of Aptus Health, Inc, formerly known as Physicians Interactive Holdings, LLC "PIH", which was sold in 2013 to Merck Global Health Innovation Fund (GHIF). PIH is one of the largest providers of online resources for healthcare information, medication samples and mobile decision support tools to healthcare professionals. Prior to founding PIH, he served as President of the Physicians Interactive Division of Allscripts from 2006 to 2008. From 2004 to 2006 Mr. Tramuto was Chief Executive Officer of i3 a global pharmaceutical services company that, prior to its sale to inVentiv Health, Inc. in 2011 was part of Ingenix (a subsidiary of UnitedHealth Group Incorporated). Prior to joining Ingenix, Mr. Tramuto was one of the founders of Protocare, Inc., a large provider of drug development services, where he served as Chief Executive and President of the Protocare Sciences Division and Corporate Officer of Protocare from 1998 to 2003. Prior to co-founding Protocare, Mr. Tramuto served as General Manager/Executive Vice President of the Home Healthcare Business Unit and Corporate Vice President of Disease Management Marketing at Caremark. Mr. Tramuto also serves on several executive leadership boards including the Boston University School of Public Health Dean's Advisory Board, Brown University's Executive Master of Healthcare Leadership Advisory Board, Chairman of Physicians Interactive Board of Directors, and as a Board Trustee at the Robert F. Kennedy Center for Justice and Human Rights Europe Board. Mr. Tramuto is the Chairman of the Board and founder of Health eVillages, and a former member of the State of Maine Economic Growth Council, an appointment by former Maine Governor John Baldacci. - Donato Tramuto，2014年6月起担任董事会主席。Tramuto是 PIH的创始人之一，该公司在2013年出售给了Merck Global Health Innovation Fund GHIF。他从2008年至今担任PIH的首席执行官和主席。PIH是为专业医学团队 提供医疗信息网络资源、药物样品和移动决策支持工具的最大的供应商之一。2006年到2008年，他担任Allscripts医生互动部门董事长。2004年到2006年，Tramuto担任i3（一家全球制药服务公司）首席执行官；i3在2011年被inVentiv Health, Inc.收购之前，曾是Ingenix（UnitedHealth Group Incorporated的子公司）的一部分。1998年到2003年，Tramuto曾是Protocare, Inc.（一个大药物开发服务供应商）创始人之一，担任Protocare科学部门董事长和首席执行官以及Protocare企业长官。共同创立Protocare之前，Tramuto曾担任Caremark家庭医疗保健业务总经理/执行副总裁以及疾病管理营销副总裁。Tramuto还担任几家执行领导董事会成员，包括the Boston University School公共卫生院长顾问委员会、医生互动董事会、the Robert F. Kennedy Center for Justice、欧洲人权委员会和York Community Hospital受托人委员会。Tramuto是Health eVillages董事会主席和创始人，还是the State of Maine Economic Growth Council前成员，由前缅因州州长John Baldacci任命。
- Donato Tramuto has served as Chief Executive Officer of the Company since November 2015. He was Chairman of the Board from June 2014 until becoming Chief ExecutiveOfficer in November 2015. From 2008 until November 2015 Mr. Tramuto served as Chief Executive Officer and Chairman of Aptus Health, Inc, formerly known as Physicians Interactive Holdings, LLC "PIH", which was sold in 2013 to Merck Global Health Innovation Fund (GHIF). PIH is one of the largest providers of online resources for healthcare information, medication samples and mobile decision support tools to healthcare professionals. Prior to founding PIH, he served as President of the Physicians Interactive Division of Allscripts from 2006 to 2008. From 2004 to 2006 Mr. Tramuto was Chief Executive Officer of i3 a global pharmaceutical services company that, prior to its sale to inVentiv Health, Inc. in 2011 was part of Ingenix (a subsidiary of UnitedHealth Group Incorporated). Prior to joining Ingenix, Mr. Tramuto was one of the founders of Protocare, Inc., a large provider of drug development services, where he served as Chief Executive and President of the Protocare Sciences Division and Corporate Officer of Protocare from 1998 to 2003. Prior to co-founding Protocare, Mr. Tramuto served as General Manager/Executive Vice President of the Home Healthcare Business Unit and Corporate Vice President of Disease Management Marketing at Caremark. Mr. Tramuto also serves on several executive leadership boards including the Boston University School of Public Health Dean's Advisory Board, Brown University's Executive Master of Healthcare Leadership Advisory Board, Chairman of Physicians Interactive Board of Directors, and as a Board Trustee at the Robert F. Kennedy Center for Justice and Human Rights Europe Board. Mr. Tramuto is the Chairman of the Board and founder of Health eVillages, and a former member of the State of Maine Economic Growth Council, an appointment by former Maine Governor John Baldacci.
高管简历
中英对照 | 中文 | 英文- Glenn Hargreaves
Glenn Hargreaves自2012年7月任公司首席财务官，自2011年1月任公司财务总管。并自2005年4月至2011年1月任公司税务主任。
Glenn Hargreaves. Interim Chief Financial Officer since November 2016. Chief Accounting Officer of the Company since July 2012 and Controller since January 2011. Director of Tax of the Company from April 2005 until January 2011.- Glenn Hargreaves自2012年7月任公司首席财务官，自2011年1月任公司财务总管。并自2005年4月至2011年1月任公司税务主任。
- Glenn Hargreaves. Interim Chief Financial Officer since November 2016. Chief Accounting Officer of the Company since July 2012 and Controller since January 2011. Director of Tax of the Company from April 2005 until January 2011.
- Mary Flipse
Mary Flipse自2012年7月起，任公司总法律顾问。自2012年2月至2012年7月任公司法律顾问及董事。自2011年8月至2012年2月任公司业务顾问，自2005年5月至2011年7月任King制药公司总顾问助理。
Mary Flipse. Chief Legal Officer since November 2015. General Counsel of the Company from July 2012 to March 2016. Director, Corporate Counsel of the Company from February 2012 to July 2012. Operations Counsel of the Company from August 2011 until February 2012. Assistant General Counsel of King Pharmaceuticals from May 2005 to July 2011.- Mary Flipse自2012年7月起，任公司总法律顾问。自2012年2月至2012年7月任公司法律顾问及董事。自2011年8月至2012年2月任公司业务顾问，自2005年5月至2011年7月任King制药公司总顾问助理。
- Mary Flipse. Chief Legal Officer since November 2015. General Counsel of the Company from July 2012 to March 2016. Director, Corporate Counsel of the Company from February 2012 to July 2012. Operations Counsel of the Company from August 2011 until February 2012. Assistant General Counsel of King Pharmaceuticals from May 2005 to July 2011.
- Donato Tramuto
Donato Tramuto，2014年6月起担任董事会主席。Tramuto是 PIH的创始人之一，该公司在2013年出售给了Merck Global Health Innovation Fund GHIF。他从2008年至今担任PIH的首席执行官和主席。PIH是为专业医学团队 提供医疗信息网络资源、药物样品和移动决策支持工具的最大的供应商之一。2006年到2008年，他担任Allscripts医生互动部门董事长。2004年到2006年，Tramuto担任i3（一家全球制药服务公司）首席执行官；i3在2011年被inVentiv Health, Inc.收购之前，曾是Ingenix（UnitedHealth Group Incorporated的子公司）的一部分。1998年到2003年，Tramuto曾是Protocare, Inc.（一个大药物开发服务供应商）创始人之一，担任Protocare科学部门董事长和首席执行官以及Protocare企业长官。共同创立Protocare之前，Tramuto曾担任Caremark家庭医疗保健业务总经理/执行副总裁以及疾病管理营销副总裁。Tramuto还担任几家执行领导董事会成员，包括the Boston University School公共卫生院长顾问委员会、医生互动董事会、the Robert F. Kennedy Center for Justice、欧洲人权委员会和York Community Hospital受托人委员会。Tramuto是Health eVillages董事会主席和创始人，还是the State of Maine Economic Growth Council前成员，由前缅因州州长John Baldacci任命。
Donato Tramuto has served as Chief Executive Officer of the Company since November 2015. He was Chairman of the Board from June 2014 until becoming Chief ExecutiveOfficer in November 2015. From 2008 until November 2015 Mr. Tramuto served as Chief Executive Officer and Chairman of Aptus Health, Inc, formerly known as Physicians Interactive Holdings, LLC "PIH", which was sold in 2013 to Merck Global Health Innovation Fund (GHIF). PIH is one of the largest providers of online resources for healthcare information, medication samples and mobile decision support tools to healthcare professionals. Prior to founding PIH, he served as President of the Physicians Interactive Division of Allscripts from 2006 to 2008. From 2004 to 2006 Mr. Tramuto was Chief Executive Officer of i3 a global pharmaceutical services company that, prior to its sale to inVentiv Health, Inc. in 2011 was part of Ingenix (a subsidiary of UnitedHealth Group Incorporated). Prior to joining Ingenix, Mr. Tramuto was one of the founders of Protocare, Inc., a large provider of drug development services, where he served as Chief Executive and President of the Protocare Sciences Division and Corporate Officer of Protocare from 1998 to 2003. Prior to co-founding Protocare, Mr. Tramuto served as General Manager/Executive Vice President of the Home Healthcare Business Unit and Corporate Vice President of Disease Management Marketing at Caremark. Mr. Tramuto also serves on several executive leadership boards including the Boston University School of Public Health Dean's Advisory Board, Brown University's Executive Master of Healthcare Leadership Advisory Board, Chairman of Physicians Interactive Board of Directors, and as a Board Trustee at the Robert F. Kennedy Center for Justice and Human Rights Europe Board. Mr. Tramuto is the Chairman of the Board and founder of Health eVillages, and a former member of the State of Maine Economic Growth Council, an appointment by former Maine Governor John Baldacci.- Donato Tramuto，2014年6月起担任董事会主席。Tramuto是 PIH的创始人之一，该公司在2013年出售给了Merck Global Health Innovation Fund GHIF。他从2008年至今担任PIH的首席执行官和主席。PIH是为专业医学团队 提供医疗信息网络资源、药物样品和移动决策支持工具的最大的供应商之一。2006年到2008年，他担任Allscripts医生互动部门董事长。2004年到2006年，Tramuto担任i3（一家全球制药服务公司）首席执行官；i3在2011年被inVentiv Health, Inc.收购之前，曾是Ingenix（UnitedHealth Group Incorporated的子公司）的一部分。1998年到2003年，Tramuto曾是Protocare, Inc.（一个大药物开发服务供应商）创始人之一，担任Protocare科学部门董事长和首席执行官以及Protocare企业长官。共同创立Protocare之前，Tramuto曾担任Caremark家庭医疗保健业务总经理/执行副总裁以及疾病管理营销副总裁。Tramuto还担任几家执行领导董事会成员，包括the Boston University School公共卫生院长顾问委员会、医生互动董事会、the Robert F. Kennedy Center for Justice、欧洲人权委员会和York Community Hospital受托人委员会。Tramuto是Health eVillages董事会主席和创始人，还是the State of Maine Economic Growth Council前成员，由前缅因州州长John Baldacci任命。
- Donato Tramuto has served as Chief Executive Officer of the Company since November 2015. He was Chairman of the Board from June 2014 until becoming Chief ExecutiveOfficer in November 2015. From 2008 until November 2015 Mr. Tramuto served as Chief Executive Officer and Chairman of Aptus Health, Inc, formerly known as Physicians Interactive Holdings, LLC "PIH", which was sold in 2013 to Merck Global Health Innovation Fund (GHIF). PIH is one of the largest providers of online resources for healthcare information, medication samples and mobile decision support tools to healthcare professionals. Prior to founding PIH, he served as President of the Physicians Interactive Division of Allscripts from 2006 to 2008. From 2004 to 2006 Mr. Tramuto was Chief Executive Officer of i3 a global pharmaceutical services company that, prior to its sale to inVentiv Health, Inc. in 2011 was part of Ingenix (a subsidiary of UnitedHealth Group Incorporated). Prior to joining Ingenix, Mr. Tramuto was one of the founders of Protocare, Inc., a large provider of drug development services, where he served as Chief Executive and President of the Protocare Sciences Division and Corporate Officer of Protocare from 1998 to 2003. Prior to co-founding Protocare, Mr. Tramuto served as General Manager/Executive Vice President of the Home Healthcare Business Unit and Corporate Vice President of Disease Management Marketing at Caremark. Mr. Tramuto also serves on several executive leadership boards including the Boston University School of Public Health Dean's Advisory Board, Brown University's Executive Master of Healthcare Leadership Advisory Board, Chairman of Physicians Interactive Board of Directors, and as a Board Trustee at the Robert F. Kennedy Center for Justice and Human Rights Europe Board. Mr. Tramuto is the Chairman of the Board and founder of Health eVillages, and a former member of the State of Maine Economic Growth Council, an appointment by former Maine Governor John Baldacci.